| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 602 | 11.026 | 23.040 | 29.580 | 39.811 | 53.665 | 47.618 |
| Total Income - EUR | - | - | - | 602 | 11.026 | 23.041 | 29.590 | 39.811 | 54.435 | 49.349 |
| Total Expenses - EUR | - | - | - | 3.449 | 4.593 | 15.497 | 19.354 | 17.492 | 27.713 | 36.765 |
| Gross Profit/Loss - EUR | - | - | - | -2.847 | 6.433 | 7.544 | 10.237 | 22.319 | 26.721 | 12.583 |
| Net Profit/Loss - EUR | - | - | - | -2.847 | 6.013 | 6.853 | 9.349 | 21.503 | 26.177 | 10.009 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
Check the financial reports for the company - Duraleus Doc S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 361 | 187.404 | 207.776 | 290.601 | 285.371 | 433.282 | 465.518 |
| Current Assets | - | - | - | 105.447 | 6.083 | 8.103 | 82.549 | 142.330 | 15.413 | 16.585 |
| Inventories | - | - | - | 0 | 13 | 1.212 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 104.517 | 4.365 | 5.500 | 79.408 | 140.077 | 11.698 | 13.712 |
| Cash | - | - | - | 931 | 1.705 | 1.392 | 3.140 | 2.253 | 3.715 | 2.873 |
| Shareholders Funds | - | - | - | -2.804 | 3.263 | 10.054 | 19.180 | 33.907 | 45.698 | 55.452 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 108.613 | 190.225 | 205.826 | 353.970 | 393.794 | 402.997 | 426.651 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6810 - 6810" | |||||||||
| CAEN Financial Year |
6810
|
|||||||||
Comments - Duraleus Doc S.r.l.